Latest Cancer News

Clinical Trial Shows Best Outcomes to Date for Older Hodgkin Lymphoma Patients (09-18-2018)
Recently published results of a phase 2 clinical trial have shown the best outcomes to date for newly diagnosed older Hodgkin lymphoma patients treated with brentuximab vedotin given before and after doxorubicin,... Continue Reading

First In Class Immunostimulating Anticancer Agent able to Directly Inhibit Tumor Signaling and Kill Tumor Cells, is in Clinical Trial for Glioblastoma and Melanoma Metastatic to the Brain (09-13-2018)
Small molecule lead drug candidate blocks a critical target for tumors and crosses the blood brain barrier; begins first brain cancer patient dosing in clinical trial at MD Anderson Cancer Center HOUSTON,... Continue Reading

Targeted Combination Treatment for Melanoma now Available (09-10-2018)
The US Food and Drug Administration (FDA) approved the combination of Bratovi (encorafenib) and Mektovi (binimetinib)for use in patients with unresectable or metastatic melanoma with a BRAF V600E or... Continue Reading

More Cancer News

Locations

Jackson
322 Hospital Boulevard
Jackson, TN 38305
731-668-1668
800-870-5471
Dyersburg
440 Wilkinson Drive
Dyersburg, TN 38024
731 285-2211
888-748-8511
Paris
1290 Kelley Drive
Paris, TN 38242
731-644-3522
800-221-0948
Union City
1209 Reelfoot Ave.
Union City, TN 38261
731-884-8611
888-941-8611